Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1635Carcinoma, Renal Cell 504Urinary Bladder Neoplasms 462Carcinoma, Transitional Cell 233Breast Neoplasms 227Kidney Neoplasms 218Neoplasms 194Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 171Ovarian Neoplasms 162Melanoma 162Neoplasm Metastasis 144Lung Neoplasms 128Non-Muscle Invasive Bladder Neoplasms 107Pancreatic Neoplasms 102Stomach Neoplasms 101Uterine Cervical Neoplasms 92Squamous Cell Carcinoma of Head and Neck 86Endometrial Neoplasms 83Sarcoma 76Carcinoma, Hepatocellular 76Esophageal Neoplasms 72Head and Neck Neoplasms 69Adenocarcinoma 67Triple Negative Breast Neoplasms 66Colonic Neoplasms 53Testicular Neoplasms 52Disease 47Wilms Tumor 46Urologic Neoplasms 46

Interventions

radium Ra 223 dichloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Metastatic Castration-resistant Prostate Cancer × Genitourinary × 1 year × Clear all
NCT04521361 2025-09-19

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Bayer

Phase 1 Completed
46 enrolled
Genitourinary

Bone Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡